科研之友
微信
新浪微博
Facebook
分享链接
摘要
Although current guidelines do not set specific targets for lowering levels of low-density lipoprotein cholesterol (LDL-C), several lines of evidence support the concept that "lower is better." Statin drugs in combination with new agents now make it possible to lower LDL-C to new lows. Determining the risk of cardiovascular disease in apparently healthy adults and how far to extend treatment for primary prevention has critical implications for public health.
- 出版日期2016-3
